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Background: To present our findings in a case of Werner syndrome with refractory cystoid macular edema (CME)
and to determine the expression and the distribution of WRN proteins in human retinas.
Case presentation: A 35-year-old man with Werner syndrome who developed CME after YAG laser treatment was
studied. Optical coherence tomographic (OCT) scans were used to examine the CME in the right eye. The patient
received topical eye drops (0.1% bromfenac sodium hydrate twice daily and 1% dorzolamide hydrochloride thrice
daily), sub-Tenon triamcinolone injection thrice, intravitreal bevacizumab injection twice, and pars plana vitrectomy
of the right eye. Genetic analyses were performed to diagnose the disease. To examine the expression and
distribution of WRN proteins in the retinas, immunohistochemistry for WRN proteins was performed in human
retinas. The CME in the right eye was not improved by any of the treatments. During the follow-up period, CME
developed in the left eye. Genetic analyses detected compound heterozygosity, Mut4 and Mut11, in the WRN gene
and the individual was diagnosed with Werner syndrome. Immunohistochemical analysis of WRN proteins
expression in human retinas showed that WRN proteins were expressed in the parts of the Müller cells in the inner
nuclear layer and outer nuclear layer.
Conclusion: Patients with Werner syndrome can develop severe CME after laser treatment. A pathological link may
exist between mutations in the WRN gene and the development of CME in patients with Werner syndrome.
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Werner syndrome is one of the genetic progeria dis-
orders with autosomal recessive inheritance, and it is
caused by mutations of the Werner syndrome (WRN)
gene [1-3]. The WRN gene is found on chromosome
8p12 which is located at a RecQ type DNA/RNA heli-
case [1-3]. The wild type WRN protein is associated with
replication, repair, recombination, and transcription of
DNA [1-3]. The results of an earlier study indicated that
WRN proteins were present in neuronal and glial cells
in the brain [4]. However, there has been no report of
their expression and distribution in adult human retinas.* Correspondence: Tarii@aol.com
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unless otherwise stated.Werner syndrome is considered to be a model of hu-
man aging and is characterized by baldness, cataracts in
the twenties, atrophy of the skin, type II diabetes melli-
tus usually in the thirties, arteriosclerosis in the forties,
and increased incidences of malignant cancers in the
mid-forties [1-3,5]. Only 1400 individuals have been di-
agnosed with Werner syndrome in the world and 75%
of them are Japanese [5].
The initial finding of patients with Werner syndrome
has been juvenile cataracts found during ophthal-
mological examinations [6]. However, the incidence of
eye diseases has been low compared to skin atrophy and
sclerosis, prominent characteristics of patients with
Werner syndrome [5].
We report a case of Werner syndrome accompanied
by refractory cystoid macular edema (CME). In addition,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of the WRN proteins in adult human retinas by
immunohistochemistry.
Case presentation
A 35-year-old man underwent bilateral cataract surgeries
at 25-years-of-age. At the 32 years, he underwent
Neodymiun-YAG laser posterior capsulotomy in the
right eye because his right visual acuity had decreased to
0.7. Immediately after the YAG laser treatment, CME
developed in the right eye and he was referred to Chiba
University Hospital.
Our examination showed that his decimal visual acu-
ities were 0.5 OD and 1.0 OS. The intraocular pressures
were within normal limits. The anterior segments were
normal and both eyes were pseudophakic but fluorescein
angiography (FAG) and optical coherence tomographic
(OCT) scans showed CME in the right eye (Figure 1).
At 27-years-of-age, he underwent bipolar hip arthro-
plasty for bilateral idiopathic osteonecrosis of the fe-
moral heads. Around this period, the patient noticed a
loss of hair and hallux valgus. At the age of 33 years, he
underwent skin grafting for a skin ulcer on his right leg,
and at 35 years, bilateral calcification of the achilles
tendon was detected from X-ray images. Atrophy of
the skin in both legs was also found. He had no family
history of Werner syndrome.
According to the cardinal signs and symptoms of
the diagnostic criteria for Werner syndrome on theFigure 1 Initial findings of retinal abnormalities in patient with Werne
coherence tomographic (OCT; B) findings. The patient’s visual acuity was 0
images. FAG showed high fluorescent signals near the lower arcade of theInternational Registry website, the patient had bilateral
cataract, characteristic dermatological pathology including
ulceration, atrophic skin, and thinning of the scalp hair.
Additional examinations revealed that the patient had
hypogonadism, osteoporosis, soft tissue calcification, and
hoarse voice that are further signs of Werner syndrome.
These characteristics in our patient met the diagnostic cri-
teria of “Probable Werner syndrome” on the International
Registry of Werner syndrome website (http://www.wer-
nersyndrome.org/registry/diagnostic.html).
Our patient underwent genetic analysis in the Department
of Medicine of Chiba University Hospital and was diagnosed
with Werner syndrome. This was based on WRN gene, also
called RecQL2 or RecQ3, DNA mutation analysis, which in-
dicated that the patient carried the Mut4 and Mut11 muta-
tions (compound heterozygote) in the WRN gene of the
RecQ helicase gene family. The Werner syndrome protein,
WRN, is one of five conserved members of the RecQ
helicase family associated with premature aging [1-3].
We first considered a diagnosis of Irvine-Gass syn-
drome after Neodymium-YAG laser posterior capsulo-
tomy [7], and used topical 0.1% bromfenac sodium
hydrate and 1% dorzolamide hydrochloride. In addition,
sub-tenon administration of 20 mg triamcinolone aceto-
nide (STTA) was given, and the CME slightly improved
and his visual acuity improved to 1.0 OD. However du-
ring the followed-up period, a recurrence of the CME
was observed. Although he underwent three STTA and
two intravitreal bevacizumab (IVB) injections, the CMEr syndrome. Fluorescein angiographic (FAG; A) and optical
.5 OD. CME was detected in the right eye in both FAG and OCT
right eye indicating damage of the retinal pigment epithelium (A).
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vitrectomy to create a posterior vitreous detachment but
the CME did not improve. His right visual acuity was
subsequently 1.0 OD but he suffered from metamor-
phopsia. During the follow-up period, CME developed
in his left eye (Figure 2) despite receiving 1% dorzola-
mide hydrochloride eye drops and good visual acuity
without metamorphopsia.
Immunohistochemistry
Five normal eyes (64 ± 12 years) were obtained from the
National Disease Research Interchange (NDRI, Philadelphia,
PA). The human donor eyes from the NDRI were deliv-
ered within 48 hours postmortem on ice. The donor in-
formation provided from NDRI indicated that the eyes
were normal with no ocular eye diseases and no dia-
betes mellitus. Upon receiving the eyes, the retinas
were immediately isolated followed by fixation in 4%
paraformaldehyde for immunohistochemistry. The ret-
inas were cryosectioned and stored at -20°C.
Epiretinal membranes that were surgically removed
from patients with proliferative diabetic retinopathy were
fixed in 4% paraformaldehyde and used as positive con-
trols for WRN immunohistochemistry. The epiretinal
membranes were cryosectioned and stored at -20°C.
After blocking with 3% bovine serum albumin and 5%
goat serum in 0.1 M phosphate buffer saline (PBS), sec-
tions were incubated with rabbit anti-WRN antibody
(H-300; Santa Cruz Biotechnology, Santa Cruz, CA; sc-5629)
at 4°C overnight [8-13]. After washing with 0.1 M PBS,Figure 2 Retinal abnormalities detected by FAG (A) and OCT (B) 1 yea
developed in both eyes (A, B). FAG shows new window defects near the uthe retinal and epiretinal membrane sections were incu-
bated with fluorescein isothiocyanate (FITC)-conjugated
anti-rabbit IgG for 1 h at room temperature. Next, the
retinal sections were washed with 0.1 M PBS and incu-
bated with mouse anti-vimentin, glial fibrillary acidic pro-
tein (GFAP), rhodopsin or cone arrestin antibodies for
3 h at room temperature. Finally after washing with
0.1 M PBS, the sections were labeled with rhodamine B
isothiocyanate (RITC)-conjugated anti-mouse antibody for
1 h at room temperature. The retinal and epiretinal mem-
brane sections were co-stained with 4, 6-diamidino-2-
phenyl indole (DAPI) to label nuclei. The specificity of
the antibodies was confirmed by omitting the primary
antibodies. After mounting, the sections were immediately
observed under a fluorescence microscope. This research
protocol was approved by the Institutional Review Board
of the hospital. All procedures were performed according
to the provisions of the Declaration of Helsinki.
In adult human retinas, the WRN proteins are
expressed mainly in the Müller cells of the inner nuclear
layer (INL), and partially in the outer nuclear layer (ONL)
and in the outer plexiform layer (Figure 3A-C). WRN
positive cells had vimentin-positive signals, but not GFAP-
positive signals, and the WRN-positive cells in the ONL
co-existed with vimentin-positive signals (Figure 3A-C).
These findings indicated that the WRN proteins were
expressed in Müller cells in the INL or the ONL but not
expressed in astrocytes [14,15]. In addition, WRN proteins
were partially expressed in both rods and cones of the
ONL (Figure 3D). The localization of WRN proteinr after vitrectomy. The patient’s visual acuities were 1.0 OU. CME
pper arcade of the left eye (A).
Figure 3 Expression and localization of WRN proteins in human retinas. WRN protein signals (green) were detected in the inner nuclear
layer (INL; yellow arrows) (A) and the outer nuclear layer (ONL; white arrow) (B, C). The WRN protein signals co-existed with vimentin signals
(red; yellow arrows) (A) but not with GFAP signals (red; C). These results indicate that the WRN proteins are expressed in the cytosol of Müller
cells in human retinas. The upper picture of Panel D shows the rhodopsin signals (red) coexisted with WRN signals (green) in the ONL (D). The
lower picture of Panel D shows the cone arrestin signals (red) coexisted with WRN signals (green) in the ONL (D). Panel E shows expression and
localization of WRN proteins in epiretinal membrane of another patient with proliferative diabetic retinopathy. WRN protein signals (green) were
identified in the nucleus (E). Blue signals showed DAPI-stained nuclei. Blue signals showed DAPI-stained nuclei. GCL; ganglion cell layer, INL; inner
nuclear layer, ONL; outer nuclear layer, VM; vimentin, GFAP; glial fibrillary acidic protein. Bars = 20 μm.
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cytosol especially surrounding the nucleus (Figure 3A-C).
On the other hand, WRN expression in the epiretinal
membrane was identified in the nucleus (Figure 3E).
These results suggested that the WRN proteins
expressed in Müller cells may have other roles than that
of a DNA helicase in the nucleus.
Conclusions
Earlier, Jonas et al. reported that three of eighteen eyes
with Werner syndrome that underwent cataract surgerydeveloped postoperative CME [16]. Kocabora et al. re-
ported on a sister and a brother with Werner syndrome
who underwent bilateral cataract surgeries, and one of
the four eyes developed postoperative CME but it was
easily treated with topical indomethacin [17]. CME is
also frequently present in patients with retinitis pigmen-
tosa and Usher syndrome [18,19]. However, our patient
had normal retinal function in both eyes.
Vitreous traction was also not the cause of the CME
in our case because vitrectomy did not resolve the CME.
In addition, the CME was not due to inflammation
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though the CME in the right eye may be related to the
Irvine-Gass syndrome, CME also developed in the left
eye. Thus, the pathogenesis of CME was most likely
associated with the mutations in the WRN gene.
TheWRN gene, also called the RecQL2 or RecQ3 gene, is
identified as a RecQ type DNA/RNA helicase [20]. There
are five members of the RecQ helicases; WRN and RecQ4
are members of the RecQ helicases associated with prema-
ture aging and cancer predisposition [1-3,5]. More than 30
WRN mutations have been identified in patients with Wer-
ner syndrome [1-3,5]. Some Werner syndrome patients de-
velop type II diabetes mellitus [1-3,5], which may be related
to abnormal WRN expression in the pancreas [21].
Gee et al. demonstrated that the WRN proteins were
expressed in neurons and glial cells of the brain [4]. In
addition, they identified WRN protein expression in the
very distal regions of neuritic processes of brain primary
neurons in vitro [4]. Our results showed that the WRN
proteins were expressed in the cytosol of Müller cells of
normal retinas from elderly people. It is possible that WRN
proteins may have other functions than that of DNA heli-
case or exonuclease in the cytosol. For example, WRN pro-
teins may be involved in the regulation of apoptosis
because they can interact with p53 and activate p53-
dependent transcription of p21/Waf1 [1,22]. The results of
earlier studies indicated that pathological changes, such as
swelling and death of Müller cells, were closely related to
the onset of CME [23,24]. Laeffler et al. suggested that the
pathologic changes of dominantly inherited CME affected
mainly Müller cells [24]. The absence of WRN protein ex-
pression in Müller cells in patients with Werner syndrome
may cause the development of the CME associated with
Müller cell dysfunction [25].
Taken together, our results suggest a pathophysiological
link between WRN protein expression in Müller cells and
the development of refractory CME associated with Werner
syndrome.
In conclusion, we report a case of refractory CME that
developed in a patient with Werner syndrome. The ex-
pression of WRN proteins in Müller cells of adult human
retinas indicates that WRN gene is active in Müller cells,
and therefore a pathophysiological link may exist between
the mutation in the WRN gene and the development of
CME in patients with Werner syndrome. Further studies
are needed to demonstrate the precise role of WRN pro-
teins expression in Müller cells and their association with
the development of CME.
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